# C-Cure Clinical Trial

> **NCT00810238** · PHASE2,PHASE3 · COMPLETED · sponsor: **Celyad Oncology SA** · enrollment: 240 (estimated)

## Conditions studied

- Heart Failure Class II or III

## Interventions

- **BIOLOGICAL:** C-Cure

## Key facts

- **NCT ID:** NCT00810238
- **Lead sponsor:** Celyad Oncology SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-07
- **Final completion:** 2012-01
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2012-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00810238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00810238, "C-Cure Clinical Trial". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00810238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*